<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lazari LC</submitter><funding>Conselho Nacional de Desenvolvimento Científico e Tecnológico</funding><funding>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior</funding><funding>Fundação de Amparo à Pesquisa do Estado de São Paulo</funding><funding>Pró-Reitoria de Pesquisa da Universidade de São Paulo</funding><pagination>2043651</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8890567</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The SARS-CoV-2 infections are still imposing a great public health challenge despite the recent developments in vaccines and therapy. Searching for diagnostic and prognostic methods that are fast, low-cost and accurate are essential for disease control and patient recovery. The MALDI-TOF mass spectrometry technique is rapid, low cost and accurate when compared to other MS methods, thus its use is already reported in the literature for various applications, including microorganism identification, diagnosis and prognosis of diseases.&lt;h4>Methods&lt;/h4>Here we developed a prognostic method for COVID-19 using the proteomic profile of saliva samples submitted to MALDI-TOF and machine learning algorithms to train models for COVID-19 severity assessment.&lt;h4>Results&lt;/h4>We achieved</pubmed_abstract><journal>Journal of oral microbiology</journal><pubmed_title>MALDI-TOF mass spectrometry of saliva samples as a prognostic tool for COVID-19.</pubmed_title><pmcid>PMC8890567</pmcid><funding_grant_id>2021.1.10424.1.9</funding_grant_id><pubmed_authors>Santiago VF</pubmed_authors><pubmed_authors>Sarmento DJS</pubmed_authors><pubmed_authors>To K</pubmed_authors><pubmed_authors>Marinho CRF</pubmed_authors><pubmed_authors>Braz-Silva PH</pubmed_authors><pubmed_authors>Almeida JD</pubmed_authors><pubmed_authors>Martinho H</pubmed_authors><pubmed_authors>Giannecchini S</pubmed_authors><pubmed_authors>Durigon EL</pubmed_authors><pubmed_authors>Rosa-Fernandes L</pubmed_authors><pubmed_authors>Angeli CB</pubmed_authors><pubmed_authors>Palmieri M</pubmed_authors><pubmed_authors>Palmisano G</pubmed_authors><pubmed_authors>Zerbinati RM</pubmed_authors><pubmed_authors>Lazari LC</pubmed_authors><pubmed_authors>Lindoso JAL</pubmed_authors><pubmed_authors>Rosa KF</pubmed_authors><pubmed_authors>Sabino EC</pubmed_authors><pubmed_authors>Schwab G</pubmed_authors><pubmed_authors>Wrenger C</pubmed_authors></additional><is_claimable>false</is_claimable><name>MALDI-TOF mass spectrometry of saliva samples as a prognostic tool for COVID-19.</name><description>&lt;h4>Background&lt;/h4>The SARS-CoV-2 infections are still imposing a great public health challenge despite the recent developments in vaccines and therapy. Searching for diagnostic and prognostic methods that are fast, low-cost and accurate are essential for disease control and patient recovery. The MALDI-TOF mass spectrometry technique is rapid, low cost and accurate when compared to other MS methods, thus its use is already reported in the literature for various applications, including microorganism identification, diagnosis and prognosis of diseases.&lt;h4>Methods&lt;/h4>Here we developed a prognostic method for COVID-19 using the proteomic profile of saliva samples submitted to MALDI-TOF and machine learning algorithms to train models for COVID-19 severity assessment.&lt;h4>Results&lt;/h4>We achieved</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-04T19:58:12.476Z</modification><creation>2025-04-04T19:58:12.476Z</creation></dates><accession>S-EPMC8890567</accession><cross_references><pubmed>35251522</pubmed><doi>10.1080/20002297.2022.2043651</doi></cross_references></HashMap>